Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-14

The role of the neural cell adhesion molecule L1 and its ligands in normal brain development and hereditary brain diseases

Objective



During development of the nervous system, axonal growth, neuronal migration and synapse formation are essential. As the embryonic nervous system differentiates, neurons produce axons that travel through diverse and changing environments of the developing animal to find their appropriate targets. When target cells are reached, synapses are formed. Synaptic plasticity is important, not only during establishment of the neural network, but also in the adult organism in which a continuous modulation of synaptic connections is essential for the dynamic functions of the brain such as learning and memory storage. An understanding of the molecular basis of axonal growth and guidance both during normal development and in relation to brain diseases is therefore an important issue in developmental neurobiology as well as in clinical neurology and neuropathology.
The aims of the proposed collaboration are to provide an extensive characterization of a key molecule, the neural cell adhesion molecule L1, involved in axonal growth, neuronal migration and synaptic plasticity. The characterization includes localization of binding sites for the homophilic (L1) and heterophilic ligands the cell adhesion molecules Axonin- 1, F11, NCAM and laminin. Furthermore, L1 interaction with the fibroblast growth factor receptor, which probably mediates signal transduction, will be characterised in detail. The binding sites will be characterised in regard to their localization, structure and binding affinities, thus enabling the preparation of agonistic and antagonistic ligands, which may allow the development of compounds beneficial for the treatment of neuro-degenerative disorders. The proposed collaboration involves seven leading European laboratories, six academic and one industrial laboratory. The partners will combine different fields, disciplines and techniques in order to exploit complementary approaches in an integrated manner allowing the achievement of results, which cannot otherwise be obtained. The collaboration will also contain a training element in molecular biological and pharmacological methodology, and it is intended to develop theoretical and practical insights and strategies by means of a progressive series of intensive workshops. By the conclusion of the project, we expect to have identified the major macromolecular ligands of L1, and to have determined their binding sites, binding affinities and effects. Ligands, fragments of ligands and artificial ligands will have been prepared and tested for agonistic and antagonistic effects in-vitro and in-vivo. Finally, these findings will be disseminated by specialist, review and popular articles and conference presentations, providing a platform for future pharmacological developments in the fields of neurodegenerative disorders.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

CSC - Cost-sharing contracts

Coordinator

UNIVERSITY OF COPENHAGEN
EU contribution
No data
Address
3,Blegdamsvej 3C
2200 KOEPENHAGEN
Denmark

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (6)

My booklet 0 0